Literature DB >> 34020036

Pseudouridine RNA modification detection and quantification by RT-PCR.

Wen Zhang1, Tao Pan2.   

Abstract

Pseudourine (Ψ) is the most abundant cellular RNA modification, present in tRNA, rRNA, snRNA, mRNA, long noncoding RNA (lncRNA), and others. Ψ sites and fractions are dynamically regulated in stress response and across development stages. Although high throughput Ψ sequencing methods based on N-Cyclohexyl-N'-(2-morpholinoethyl)carbodiimide (CMC) reaction are available for Ψ detection transcriptome-wide, a simple method for the analysis of specific, targeted Ψ sites and their fraction quantitation is needed to better investigate Ψ function. Here, we describe an RT-PCR and gel electrophoresis based method that can sensitively and quantitatively assess Ψ at single-nucleotide resolution in mRNA/lncRNA, termed CMC-RT and ligation assisted PCR analysis of Ψ modification (CLAP). The principle of the CMC-method is the reverse transcription stop induced by the CMC-Ψ adduct. In CLAP, CMC reaction is first carried out with the RNA sample. Reverse transcription using a non-processive RT produces two cDNA products for each RNA transcript, one with the 3' end at the Ψ site, the other read-through product from the unmodified RNA. Using splint oligonucleotide assisted site-specific ligation, these two cDNA products are then visualized on a gel as two distinct PCR products in the same lane corresponding to the Ψ-modified and unmodified target site. CLAP validates Ψ sites identified by high throughput sequencing, quantifies Ψ levels in mRNA and lncRNA, and enables convenient and rapid investigation on the function and mechanism of the Ψ modification.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CMC; Pseudouridine; RT-PCR; lncRNA; mRNA

Mesh:

Substances:

Year:  2021        PMID: 34020036      PMCID: PMC8599501          DOI: 10.1016/j.ymeth.2021.05.010

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   4.647


  3 in total

Review 1.  Dysregulation of Small Nucleolar RNAs in B-Cell Malignancies.

Authors:  Martijn W C Verbeek; Stefan J Erkeland; Vincent H J van der Velden
Journal:  Biomedicines       Date:  2022-05-24

Review 2.  Emerging Roles of Long Noncoding RNAs in Breast Cancer Epigenetics and Epitranscriptomics.

Authors:  Elżbieta Wanowska; Klaudia Samorowska; Michał Wojciech Szcześniak
Journal:  Front Cell Dev Biol       Date:  2022-07-05

3.  High-grade ovarian cancer associated H/ACA snoRNAs promote cancer cell proliferation and survival.

Authors:  Laurence Faucher-Giguère; Audrey Roy; Gabrielle Deschamps-Francoeur; Sonia Couture; Ryan M Nottingham; Alan M Lambowitz; Michelle S Scott; Sherif Abou Elela
Journal:  NAR Cancer       Date:  2022-01-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.